SYK Add to watchlist
$348.15 +2.34 (+0.68%)
After Hours: $348.15 +0.00 (+0.00%)
Last updated: Aug 11, 2026 20:42
52-Week Range
$348.15
$281.00 $348.15 $396.86

Fundamentals Overview

Stryker Corporation is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 36 PEG 1.3 P/B 5.57 P/S 5.17

Intrinsic value (DCF)

-9% downside vs price

Profitability

Net margin 14.4%

Risk (Beta)

0.77 — lower vol

Earnings & growth

EPS $9.66 Rev +9.5% Profit +71.3% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 65% confidence Risk: Lower Volatility — Beta 0.77. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · Sentiment improving (2 upgrades) · 3M vs S&P 500: +17.5%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$133.47B
P/E (TTM)
36.04
EPS (TTM)
$9.66
Dividend Yield
1%
52-Week Range
$281.00 - $396.86
Volume vs Avg
N/A
Beta
0.77

About

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, de...
Sector: Healthcare
Headquarters: US
Employees: 56,000
IPO Date: Mar 1980
Beta: 0.77 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 9, Hold: 4, Market Outperform: 1, Neutral: 3, Outperform: 7, Overweight: 6.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $316.95; current price is $348.15. That’s a -9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 36.04
DCF value (model) $316.95 (-9% vs price)
PEG (TTM) 1.3
P/B (TTM) 5.57
P/S (TTM) 5.17
P/FCF (TTM) 28.39
Liquidity & enterprise
Current Ratio (TTM) 2.16
Quick Ratio (TTM) 1.33
Cash Ratio (TTM) 0.51
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 14.43%
Gross margin (TTM) 65.17%
Operating margin (TTM) 22.03%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for SYK.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 9Hold 4Market Outperform 1Neutral 3Outperform 7Overweight 6
2 upgrades, 0 downgrades
Price Target Consensus
Current $348.15
Median $380.00
Consensus $382.61
Low consensus $315.00
High consensus $465.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
JP Morgan maintain Overweight Overweight 2026-07-31
BTIG maintain Buy Buy 2026-07-31
RBC Capital maintain Outperform Outperform 2026-07-31
Truist Securities maintain Hold Hold 2026-07-31
Piper Sandler maintain Overweight Overweight 2026-07-31
BMO Capital upgrade Market Perform Outperform 2026-07-09
Evercore ISI Group maintain Outperform Outperform 2026-07-06
Leerink Partners maintain Outperform Outperform 2026-06-05
Barclays maintain Overweight Overweight 2026-05-04
Truist Securities maintain Hold Hold 2026-05-04
Evercore ISI Group maintain Outperform Outperform 2026-05-01
BTIG maintain Buy Buy 2026-05-01
Needham maintain Buy Buy 2026-05-01
JP Morgan maintain Overweight Overweight 2026-05-01
Wells Fargo maintain Overweight Overweight 2026-05-01
Canaccord Genuity maintain Buy Buy 2026-05-01
Truist Securities maintain Hold Hold 2026-04-15
BTIG maintain Buy Buy 2026-04-14
Goldman Sachs maintain Neutral Neutral 2026-04-09
Citigroup maintain Buy Buy 2026-04-07
Evercore ISI Group maintain Outperform Outperform 2026-04-06
UBS maintain Neutral Neutral 2026-03-17
UBS maintain Neutral Neutral 2026-02-24
Barclays maintain Overweight Overweight 2026-02-02
Needham maintain Buy Buy 2026-01-30
BTIG maintain Buy Buy 2026-01-30
Bernstein maintain Outperform Outperform 2026-01-09
Citizens upgrade Market Perform Market Outperform 2025-12-19
Truist Securities maintain Hold Hold 2025-12-18
Citigroup maintain Buy Buy 2025-12-11